Colitis ulcerative
Not recruitingStudy on Vedolizumab for Patients with Active Ulcerative Colitis
- Disease:Colitis ulcerative
- Substances:Vedolizumab
Poland- Participants:18–64 years · 65+ years
- Substances:Vedolizumab
- Sponsor:Alimentiv Inc.
Rare diseases
Investigational molecules
Locations
Back to Poland117 clinical trials in Elblag, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Research focusing on plaque psoriasis and innovative treatments for moderate to severe cases. Studies evaluating novel therapeutic approaches for atopic dermatitis.
Multiple trials investigating long-term safety and efficacy of new therapeutic agents.
Comprehensive research into psoriatic arthritis treatments, including studies for both biologic-naive and experienced patients. Additional focus on Sjögren's Syndrome and innovative therapies.
Evaluating multiple therapeutic approaches for autoimmune conditions.
Studies addressing obesity and weight management through innovative treatments. Research on respiratory conditions including RSV infections and asthma management.
Focus on both preventive measures and therapeutic interventions.
Investigations into treatments for Crohn's Disease and Ulcerative Colitis, focusing on innovative therapeutic approaches for inflammatory bowel conditions.
Evaluating new therapeutic options for inflammatory bowel diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.